Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Recent Advances in Pathologic Research and Targeted Therapies of Thymoma
View through CrossRef
Thymoma is a rare tumor that was reclassified by the World Health Organization in 2015. Recent studies have made advances in molecular targeted therapies, such as c-KIT, EGFR, IGF-1R, PTEN, HDAC, VEGF and PD-L1. Additionally, new molecular markers such as CTV/CTS, GTF2I, Pax8 and DSG-3 have been used in the differential diagnosis of thymoma. This article reviews molecular pathogenesis of thymoma, application of molecular pathology in the differential diagnosis of thymoma and recent progress in targeted therapies for thymoma.
Title: Recent Advances in Pathologic Research and Targeted Therapies of Thymoma
Description:
Thymoma is a rare tumor that was reclassified by the World Health Organization in 2015.
Recent studies have made advances in molecular targeted therapies, such as c-KIT, EGFR, IGF-1R, PTEN, HDAC, VEGF and PD-L1.
Additionally, new molecular markers such as CTV/CTS, GTF2I, Pax8 and DSG-3 have been used in the differential diagnosis of thymoma.
This article reviews molecular pathogenesis of thymoma, application of molecular pathology in the differential diagnosis of thymoma and recent progress in targeted therapies for thymoma.
Related Results
Genetic characterization of thymoma
Genetic characterization of thymoma
AbstractThymoma represents the most common anterior mediastinal compartment neoplasm, originating from the epithelial cell population in the thymus. Various histological types of t...
Investigation of the prognostic biomarkers for thymoma
Investigation of the prognostic biomarkers for thymoma
Abstract
Background
Thymoma represents the most common anterior mediastinal malignancy and has a close association with autoimmune disease. However, the potential molecula...
Clinical and Genetic Characteristics of Thymoma Patients With Autoimmune Hepatitis and Myocarditis
Clinical and Genetic Characteristics of Thymoma Patients With Autoimmune Hepatitis and Myocarditis
BackgroundOur study investigated a special series of thymoma with autoimmune hepatitis and myocarditis and tried to reveal the gene expression profiles of this series of thymoma.Me...
Does size affect the prognosis of resectable thymoma beyond the eighth edition TNM?
Does size affect the prognosis of resectable thymoma beyond the eighth edition TNM?
AbstractBackgroundThymoma is a type of rare mediastinal tumor whose clinical characteristics and indicators of prognosis are poorly understood. This single‐institution retrospectiv...
#1941 About a case: ABBA disease in a patient with thymoma
#1941 About a case: ABBA disease in a patient with thymoma
Abstract
Background and Aims
ABBA (antibrush border antibody) disease is a rare autoimmune tubulointerstitial kidney disease wit...
Abstract 1776: Exploring anetumab ravtansine in a preclinical model of thymic carcinoma
Abstract 1776: Exploring anetumab ravtansine in a preclinical model of thymic carcinoma
Abstract
Thymic epithelial tumors (TETs) are a group of rare tumors (0.13 per 100,000 persons), comprised of thymomas and thymic carcinoma, arising from the epitheli...
<b>The Relationship Between Myasthenia Gravis and Thymoma and Advanced Treatment Methods</b>
<b>The Relationship Between Myasthenia Gravis and Thymoma and Advanced Treatment Methods</b>
Thymoma-associated myasthenia gravis (TAMG) is a complex autoimmune disease whose pathogenesis involves the production of anti-acetylcholine receptor antibodies induced by the abno...
Aplp1 and the Aplp1-Lag3 Complex facilitates transmission of pathologic α-synuclein
Aplp1 and the Aplp1-Lag3 Complex facilitates transmission of pathologic α-synuclein
AbstractPathologic α-synuclein (α-syn) spreads from cell-to-cell, in part, through binding to the lymphocyte-activation gene 3 (Lag3). Here we report that amyloid β precursor-like ...